Advertisement
Advertisement

AXSM

AXSM logo

Axsome Therapeutics, Inc

231.48
USD
Sponsored
-2.01
-0.86%
Jun 04, 15:59 UTC -4
Closed
exchange

Pre-Market

232.30

+0.82
+0.35%

AXSM Earnings Reports

Positive Surprise Ratio

AXSM beat 21 of 42 last estimates.

50%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$224.85M
/
-$0.84
Implied change from Q1 26 (Revenue/ EPS)
+17.60%
/
-33.33%
Implied change from Q2 25 (Revenue/ EPS)
+49.86%
/
-13.40%

Axsome Therapeutics, Inc earnings per share and revenue

On May 04, 2026, AXSM reported earnings of -1.26 USD per share (EPS) for Q1 26, missing the estimate of -0.91 USD, resulting in a -37.87% surprise. Revenue reached 191.20 million, compared to an expected 194.03 million, with a -1.46% difference. The market reacted with a +8.31% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 13 analysts forecast an EPS of -0.84 USD, with revenue projected to reach 224.85 million USD, implying an decrease of -33.33% EPS, and increase of 17.60% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
logo
Connect Biopharma Holdings Limited Ordinary Shares
Report Date
May 22, 2026 For Q1 26
Estimate
-$1.53
Actual
-$2.35
Surprise
-53.05%
FAQ
For Q1 2026, Axsome Therapeutics, Inc reported EPS of -$1.26, missing estimates by -37.87%, and revenue of $191.20M, -1.46% below expectations.
The stock price moved up 8.31%, changed from $206.53 before the earnings release to $223.70 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 13 analysts, Axsome Therapeutics, Inc is expected to report EPS of -$0.84 and revenue of $224.85M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement